Kliniska studier för Lupus i Maryland
10 studier för Lupus söker deltagare vid platser i Maryland.
Städer i Maryland
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50730, Rockville
RekryterarFas 3
Ålder 16 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06617325Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda
RekryterarObservationsstudie
Ålder 18 till 120 · Kvinnor · Uppdaterad 28 sep. 2026 · NCT05567198A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Silver Spring
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07430306Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 18 sep. 2026 · NCT05440422Study of Systemic Lupus Erythematosus
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 3 till 120 · Alla kön · Uppdaterad 16 sep. 2026 · NCT00001372A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, Baltimore
RekryterarFas 1/2
Ålder 18 till 70 · Alla kön · Uppdaterad 10 sep. 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
RekryterarFas 1
Ålder 18 till 74 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07085104A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Arthritis & Rheumatism Associates, Rockville
RekryterarObservationsstudie
Ålder 16 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT07175285Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1/2Friska volontärer välkomna
Ålder 18 till 120 · Kvinnor · Uppdaterad 31 juli 2026 · NCT06032923Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.